glp 1 agonist risks GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists Managing Side Effects of GLP-1
Description
Fadini, Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection, Curr
Therapie, die zu deinem Leben passt Unsere Diabetes App begleitet dich bei Typ-2-Diabetes, digital, auf Rezept und von der Kasse bernommen
[DOI] [PubMed] [Google Scholar] 61.Knezevich E, Crnic T, Kershaw S, Drincic A
Circulating microRNAs Signature for Predicting Response to GLP1-RA Therapy in Type 2 Diabetic Patients: A Pilot Study
